Eos Biotechnology, Inc.
Records under this name other than patents Eos Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Eos Biotechnology, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,189,507 | Methods of Diagnosis of Ovarian Cancer, Compositions and Methods of Screening for Modulators of Ovarian Cancer Formerly held Term ended Term ended Jul 12, 2024 · High confidence | Term ended | Term ended Jul 12, 2024 | High confidence |
| US 7,736,853 | Methods of Diagnosis of Androgen-Dependent Prostate Cancer, Prostate Cancer Undergoing Androgen Withdrawal, and Androgen-Independent Prostate Cancer Formerly held Term ended Term ended May 31, 2022 · Medium confidence | Term ended | Term ended May 31, 2022 | Medium confidence |
| US 6,780,586 | Methods of diagnosing breast cancer Formerly held Term ended Term ended Mar 24, 2020 · From the USPTO record | Term ended | Term ended Mar 24, 2020 | From the USPTO record |
| US 6,455,668 | Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators Term ended Term ended Jan 28, 2020 · From the USPTO record | Term ended | Term ended Jan 28, 2020 | From the USPTO record |
| US 6,566,502 | Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators Formerly held Term ended Term ended Jan 28, 2020 · From the USPTO record | Term ended | Term ended Jan 28, 2020 | From the USPTO record |
| US 6,750,013 | Methods for detection and diagnosing of breast cancer Formerly held Term ended Term ended Dec 2, 2019 · From the USPTO record | Term ended | Term ended Dec 2, 2019 | From the USPTO record |
| US 6,264,891 | Apparatus and method for concurrent chemical synthesis Formerly held Term ended Term ended May 18, 2019 · From the USPTO record | Term ended | Term ended May 18, 2019 | From the USPTO record |
| US 6,649,342 | Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators Formerly held Term ended Term ended Mar 15, 2019 · From the USPTO record | Term ended | Term ended Mar 15, 2019 | From the USPTO record |
| US 6,762,020 | Methods of diagnosing breast cancer Formerly held Term ended Term ended Mar 15, 2019 · From the USPTO record | Term ended | Term ended Mar 15, 2019 | From the USPTO record |
| US 6,316,272 | Methods of diagnosis of colorectal cancer and methods of screening for colorectal cancer modulators Formerly held Lapsed on the fee record Ended Nov 13, 2009 · From the USPTO record | Lapsed on the fee record | Ended Nov 13, 2009 | From the USPTO record |